Neil began writing code for the nuclear industry three decades ago and has since held CTO, Chief Architect, and Director roles at BT, Wipro, Fujitsu, Sopra Steria, and Capita - spanning a £1.5bn digital transformation and a landmark Google data partnership at BT, a $1bn health infrastructure programme serving 400 million people across 11 medical cities and 6,500 remote clinics at Wipro, and a five-year strategic roadmap for UK Government Home Affairs at Fujitsu.
Fractional CTO — technology strategy, delivery recovery and engineering leadership
Jerome MacGillivray has spent more than twenty-five years leading global technology teams and delivering digital platforms across regulated, customer-facing and operationally complex environments. His experience spans fintech, retail, travel, cybersecurity, robotics and AI, with roles covering CTO leadership, engineering scale-up, vendor management, platform delivery and technical recovery. He works with founders, boards and leadership teams to make technology decisions clearer, delivery more predictable, and engineering more closely aligned with business priorities.
Gloucester, UKPlatform recoveryProduct and engineering strategyVendor and technical due diligence
Fractional CTO/CIO — Health & Care, Government, Commercial | ex-NHS, ex-InHealth
With a career spanning founding and co-founding technology businesses, consultancy, interim executive, and non-executive board roles across the NHS, government, charity, and commercial sectors, Andrew has spent close to four decades helping organisations use information and technology to drive meaningful change.
Brisbane, AustraliaUK & AustraliaDigital transformationHealth & care sectorBoard advisory (NED/Interim)
Applied AI Adviser — Oxford DPhil, ex-J.P. Morgan, UBS, Citi
Berkan has worked on AI in high-stakes settings since 2009, starting with an Oxford DPhil in AI and Medical Informatics, where he built clinical decision support systems that predicted patient outcomes and recommended treatment, published in leading medical and interdisciplinary journals. He has published on AI continuously since, most recently on the evaluation of retrieval-augmented LLMs in clinical use, and writes for industry on AI transformation and clinical AI.
Fractional CTO & Board Adviser — Applied AI, WealthTech and High-Performance Teams in Regulated Markets
Neil Taggart has spent his career leading technology and product functions across financial services, wealth management and, more recently, applied AI. His experience includes two CTO roles in regulated financial markets, nearly nine years leading technology for a global strategy-execution consultancy through its acquisition by a Fortune 1000 firm, and building the technology function for a Family Office wealth management business, alongside hands-on AI coaching and product work with Tribe AI and Anthropic.
London, UKApplied AI & enterprise adoptionWealthTech & family office technologyHigh-performance team coaching
Fractional CTO/CIO & Board Adviser — Enterprise Modernization, Security & Compliance and Large-Scale Operations in Regulated Industries
Amer Murad has spent 27+ years leading technology, product and operations functions across healthcare, human capital management, education, telecom and banking. His experience includes CTO and CIO roles spanning organizations from a 300-person SaaS communications platform to a 10,000-employee not-for-profit healthcare provider, 16 years at Ceridian leading product development, technology innovation and DevOps for global HCM and payroll platforms, and building a compliance and governance function from scratch for a 45-year-old software company through its growth by acquisition. He is TOGAF 9 certified in enterprise architecture.
Hamilton, Ontario, CanadaEnterprise technology & data modernizationSecurity, risk & compliance (SOC 2, GDPR, HIPAA)Large-scale program & operations leadership
Fractional CTO — Precision Biology, Drug Discovery & Translational Science in Regulated Industries
Elad Katz has spent over two decades working at the intersection of deep biological science and commercial reality, leading translational research and venture creation across oncology, kidney, liver, cardiac, bone and women's health. His experience spans founding and leading Navigate Precision Biology, where he built the NaviPlate organoid platform from academic concept through customer discovery to commercial validation, alongside senior scientific and R&D leadership roles at Sartorius Stedim BioOutsource, amsbio, and the Universities of Edinburgh, Manchester and Pennsylvania. He holds a PhD in Immunology from the University of Glasgow and a BSc in Chemistry and Physics from the Hebrew University of Jerusalem.
Greater Dundee Area, UKPrecision medicine & drug discoveryOrganoid biology, disease modelling & assay developmentCommercial translation for biotech & pharma
Carlos spent 14 years inside TransUnion, moving from software developer to DevOps engineer to Product Owner, learning exactly how large financial institutions think, what slows them down, and where the cracks are. Then he left to help founders build things faster than those institutions ever could.
CanadaAI agentsFintech & creditEarly-stage MVPsFull-stack architectureStartup to enterprise
Gabriel began his career as a technical systems analyst and test engineer in the Israeli Air Force, reaching the rank of Major and taking part in several satellite launches, before leading system engineering and testing on large multidisciplinary programmes at Israel Aerospace Industries. He went on to senior system engineering and technical product roles at Orbotech and OSR Enterprises, then moved into regulated medical devices in Sydney as Technology Development Lead at Nanosonics and Principal Engineer for robotics and automation across Cochlear's global manufacturing operations.
Sydney, AustraliaScale-ups, pivots & health servicesMedical devices, AI, robotics, aerospaceSingle-owner projects to 400-person global teams
Fractional CTO & AI Engineer — AI for High-Compliance B2B SaaS
Márton began his career in research, completing a PhD in computer systems and networking at the Budapest University of Technology and Economics, with a research internship at Deutsche Telekom's T-Labs in Berlin, followed by four years as a postdoctoral research fellow at the Hungarian Academy of Sciences, where he published peer-reviewed research in neuroscience and distributed systems. He moved to Berlin to join KILT Protocol as Research Lead, Product Owner and Full Stack Developer, designing its self-sovereign digital identity protocol and token economics, authoring its white paper, and leading delivery from research through to mainnet, including a Deloitte-partnered KYC integration.
Ryan is an electrical and electronic engineer who began his career as a semiconductor market analyst at IMS Research, later IHS, where over a decade he built one of the industry’s leading wireless-power research practices and led international analyst teams to around 64% year-on-year revenue growth. He has worked with Aircharge for eleven years, progressing from commercial development to CTO and Managing Director, and now serves on its board as a Non-Executive Director. There he helped lead the evolution of a wireless-charging hardware business into an international physical-digital platform spanning hardware, SaaS, IoT and data, deployed across 4,500+ venues in 45+ countries with major global hospitality, QSR and technology brands.
London Area, United KingdomFounders, CEOs & leadership teamsConnected hardware, IoT, SaaS/data & AI-enabled productsProduct launch to international scale
Reon began his career as an electronic engineer at TEGEMA, a high-tech engineering company in the Eindhoven Brainport region, designing electronics and electrical systems for machines and products in semiconductor, life science and automotive markets, including his first medical products.
Fractional CTO — Scientific Computing, AI & Data for Life Sciences
Arno is a mathematician who has spent more than 25 years building software that applies algorithms and machine learning to life science questions, long before “AI” became the word for it. He joined Definiens as a software developer in 1998 and spent over two decades there, progressing through Director of Platform Development, Chief Architect, VP Product Development and VP & Chief Architect to VP Product & Innovation at Definiens, The Tissue Phenomics Company. Along the way he took the company’s image analysis technology from an early prototype to its core product, was responsible for that product for many years, and later brought up and matured new products and technologies in digital and computational pathology. Since 2020 he has been CTO of Noselab, a Munich biotech company, where he built the entire digital side of the business, from software and IT to data, along with the team behind it, working hands-on throughout. He is a named inventor on multiple patents in image analysis, has co-authored publications on tissue phenomics and cancer research, and serves as a panel CTO with CTO Grand Rounds. He holds a Diplom in Mathematics from Ludwig-Maximilians-Universität München.
Munich Area, GermanyBiotech, pharma & digital pathologyFrom research to productEarly prototype to early scaling